Health
Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer – News-Medical.Net
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis…
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC). In a new study in TheJournal of Molecular Diagnosis, published by Elsevier, investigators provide for the first time a complete overview of biomarker testing, spanning multiple treatment lines, in a single cohort of patients.
Using exploratory data analysis and process-mining techniques in a real-world…
-
General19 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News22 hours agoTips to improve engagement – Proctor
-
Noosa News21 hours agoPolice appeal for information over suspected link in torture and murder cases
-
Noosa News15 hours agoWorking for someone else made it hard to care for my daughter. So I quit